{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:03:41Z","timestamp":1792803821767,"version":"4.5.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>COVID-19 infection, its treatment, resultant immunosuppression, and pre-existing comorbidities have made patients vulnerable to secondary infections including mucormycosis. It is important to understand the presentation, temporal sequence, risk factors, and outcomes to undertake measures for prevention and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective, interventional study on six consecutive patients with COVID-19 who developed rhino-orbital mucormycosis and were managed at two tertiary ophthalmic referral centers in India between August 1 and December 15, 2020. Diagnosis of mucormycosis was based on clinical features, culture, and histopathology from sinus biopsy. Patients were treated with intravenous liposomal amphotericin B with addition of posaconazole and surgical debridement of necrotic tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>All patients were male, mean age 60.5 \u00b1 12 (46.2\u201373.9) years, type 2 diabetics with mean blood glucose level of 222.5 \u00b1 144.4 (86\u2013404) mg\/dL. Except for one patient who was diagnosed with mucormycosis concurrently with COVID-19, all patients received systemic corticosteroids for the treatment of COVID-19. The mean duration between diagnosis of COVID-19 and development of symptoms of mucor was 15.6 \u00b1 9.6 (3\u201342) days. All patients underwent endoscopic sinus debridement, whereas two patients required orbital exenteration. At the last follow-up, all six patients were alive, on antifungal therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Mucormycosis is a life-threatening, opportunistic infection, and patients with moderate to severe COVID-19 are more susceptible to it. Uncontrolled diabetes mellitus and use of corticosteroids increase the risk of invasive fungal infection with mucormycosis which can develop during the course of the illness or as a sequelae. High index of suspicion, early diagnosis, and appropriate management can improve survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_3774_20","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:20:11Z","timestamp":1611015611000},"page":"244-252","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":302,"title":["Mucor in a Viral Land"],"prefix":"10.4103","volume":"69","author":[{"given":"Mrittika","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Lahane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyarao P","family":"Lahane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragini","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh G","family":"Honavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-9-20240828","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19?","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"R4-9-20240828","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R5-9-20240828","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R6-9-20240828","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12070-018-1293-8","article-title":"Orbital exenteration in rhino-orbito-cerebral mucormycosis: A prospective analytical study with scoring system","volume":"71","author":"Shah","year":"2019","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"R7-9-20240828","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41433-019-0733-3","article-title":"Orbital mycoses in an adult subtropical population","volume":"34","author":"Lee","year":"2020","journal-title":"Eye"},{"key":"R8-9-20240828","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ajem.2019.12.002","article-title":"A multidisciplinary educational curriculum for the management of orbital compartment syndrome","volume":"38","author":"Fox","year":"2020","journal-title":"Am J Emerg Med"},{"key":"R12-9-20240828","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4103\/0301-4738.185588","article-title":"Fungal infections of the orbit","volume":"64","author":"Mukherjee","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"R13-9-20240828","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1097\/RLU.0b013e3182867d13","article-title":"Utility of 18F-FDG PET\/CT in diagnosis and management of mucormycosis","volume":"38","author":"Liu","year":"2013","journal-title":"Clin Nucl Med"},{"key":"R14-9-20240828","first-page":"68","article-title":"(18) F-FDG PET\/CT contribution to diagnosis and treatment response of rhino-orbital-cerebral mucormycosis","volume":"18","author":"Altini","year":"2015","journal-title":"Hell J Nucl Med"},{"key":"R15-9-20240828","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.iop.0000225418.50441.ee","article-title":"Indications for orbital exenteration in mucormycosis","volume":"22","author":"Hargrove","year":"2006","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R16-9-20240828","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2500\/ajr.2008.22.3121","article-title":"Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome","volume":"22","author":"Songu","year":"2008","journal-title":"Am J Rhinol"},{"key":"R17-9-20240828","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00002341-200101000-00012","article-title":"Successful treatment of rhino-orbital mucormycosis without exenteration: The use of multiple treatment modalities","volume":"17","author":"Pelton","year":"2001","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R18-9-20240828","first-page":"231","article-title":"Rhino-orbito-cerebral mucormycosis.A retrospective analysis of clinical features and treatment outcomes","volume":"51","author":"Nithyanandam","year":"2003","journal-title":"Indian J Ophthalmol"},{"key":"R19-9-20240828","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/IOP.0000000000000806","article-title":"Retrobulbar injection of amphotericin B for orbital mucormycosis","volume":"33","author":"Hirabayashi","year":"2017","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R22-9-20240828","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4103\/ijo.IJO_1415_20","article-title":"All India Ophthalmological Society-Oculoplastics Association of India consensus statement on preferred practices in oculoplasty and lacrimal surgery during the COVID-19 pandemic","volume":"68","author":"Ali","year":"2020","journal-title":"Indian J Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_3774_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:37:47Z","timestamp":1787845067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_3774_20"}},"subtitle":["A Tale of Two Pathogens"],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_3774_20","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}